Physician profile
Devon Kennedy
NPI 1245892397
$1,807.10
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $178 · 2021: $420 · 2022: $158 · 2024: $75.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,051.40 | 2019-2024 | |
| Glaukos Corporation | $287.84 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $124.83 | 2021 | |
| Sun Pharmaceutical Industries INC. | $114.96 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $85.30 | 2020 | |
| Alcon Vision LLC | $42.94 | 2022 | |
| Coopervision INC. | $26.13 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.08 | 2021 | |
| Kala Pharmaceuticals, INC. | $19.08 | 2020 | |
| Allergan, INC. | $16.14 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.